MarketPulse
C

$CSLLY

4 articles found
3 positive
0 negative
1 neutral
BenzingaBenzinga··Prnewswire

CSL Invests $1.5B in Illinois Plasma Facility Expansion, Targets 2031 Launch

CSL announces $1.5 billion expansion of Illinois plasma facility with 300+ new jobs, operational by 2031, incorporating advanced Horizon 2 technology.
CSLLYbiopharmaceuticalmanufacturing expansion
BenzingaBenzinga··Prnewswire

CSL Seqirus Lands Major Canadian Pandemic Vaccine Deal, Upgrades to Cell-Based Production

CSL Seqirus secures new pandemic preparedness contract with Canada's health agency, replacing egg-based vaccines with advanced cell-based technology for rapid production.
CSLLYpandemic preparednessinfluenza vaccine
BenzingaBenzinga··Vandana Singh

Eli Lilly's Dual-Therapy Approach Demonstrates Enhanced Efficacy in Psoriasis-Obesity Treatment

Eli Lilly's combo therapy of Taltz and Zepbound showed superior results for psoriasis-obesity patients, achieving 27.1% complete skin clearance versus 5.8% for monotherapy.
LLYCSLLYPhase 3b trialZepbound
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider Research

Fibrin Sealant Market Poised to Double to $3.57B by 2035 Amid Surgical Demand

Fibrin sealant market to double from $1.60B to $3.57B by 2035, driven by surgical demand and minimally invasive techniques despite accessibility challenges in developing regions.
JNJPFESYKMDTBAX+1market growthminimally invasive surgery